Chunyan Su

The human gut microbiome – a new and exciting avenue in cardiovascular drug discovery

Xingxing Li, Yu Du, Chunyan Su, 2019, Expert opinion on drug discovery.

Butyrate protects against high‐fat diet‐induced atherosclerosis via up‐regulating ABCA1 expression in apolipoprotein E‐deficiency mice

Xingxing Li, Yu Du, Chunyan Su, 2019, British journal of pharmacology.

A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α

Yu Du, Chunyan Su, Li Wang, 2020, EBioMedicine.

Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality

Xingxing Li, Yu Du, Chunyan Su, 2021, Nutrition & Diabetes.

Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome

Xingxing Li, Yu Du, Chunyan Su, 2021, NPJ biofilms and microbiomes.

Preparation and application of chikungunya pseudovirus containing double reporter genes

Chunyan Su, Hongqi Liu, Hongning Zhou, 2022, Scientific Reports.

In vivo overexpression of frataxin causes toxicity mediated by iron-sulfur cluster deficiency

C. Bulawa, Chunyan Su, I. Pardo, 2022, Molecular therapy. Methods & clinical development.